Align Technology, Inc. (ALGN)
USD 152.83
(-0.91%)
USD 152.83
(-0.91%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 799.03 Million USD | 22.07% |
| 2022 | 755.37 Million USD | -31.84% |
| 2021 | 976.4 Million USD | 152.19% |
| 2020 | 387.17 Million USD | -20.41% |
| 2019 | 666.02 Million USD | 4.27% |
| 2018 | 521.29 Million USD | 31.94% |
| 2017 | 391.35 Million USD | 29.56% |
| 2016 | 272.92 Million USD | 32.08% |
| 2015 | 206.63 Million USD | -2.27% |
| 2014 | 211.43 Million USD | -13.72% |
| 2013 | 178.05 Million USD | 51.06% |
| 2012 | 102.1 Million USD | 74.81% |
| 2011 | 90.36 Million USD | -1.8% |
| 2010 | 116.18 Million USD | 401.2% |
| 2009 | -20.8 Million USD | -212.15% |
| 2008 | 29.89 Million USD | -39.45% |
| 2007 | 47.24 Million USD | 266.3% |
| 2006 | -23.56 Million USD | -292.64% |
| 2005 | 12.89 Million USD | -42.07% |
| 2004 | 9.76 Million USD | 1008.46% |
| 2003 | 1.98 Million USD | 105.84% |
| 2002 | -43.73 Million USD | 43.06% |
| 2001 | -70.96 Million USD | 13.93% |
| 2000 | -78.6 Million USD | -458.11% |
| 1999 | -14.14 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 187.08 Million USD | -9.29% |
| 2024 Q3 | 95.74 Million USD | -4.95% |
| 2024 Q2 | 214.33 Million USD | 14.57% |
| 2023 Q4 | 171.54 Million USD | 3.13% |
| 2023 Q1 | 133.51 Million USD | -1.51% |
| 2023 Q2 | 171.93 Million USD | 28.77% |
| 2023 Q3 | 166.34 Million USD | -3.25% |
| 2023 FY | - USD | 22.07% |
| 2022 Q3 | 143.65 Million USD | -23.67% |
| 2022 FY | - USD | -31.84% |
| 2022 Q4 | 135.56 Million USD | -5.63% |
| 2022 Q2 | 188.19 Million USD | -4.99% |
| 2022 Q1 | 198.08 Million USD | -10.33% |
| 2021 Q3 | 261.16 Million USD | -2.88% |
| 2021 Q4 | 220.89 Million USD | -15.42% |
| 2021 Q2 | 268.9 Million USD | 19.28% |
| 2021 Q1 | 225.44 Million USD | 5.75% |
| 2021 FY | - USD | 152.19% |
| 2020 FY | - USD | -20.41% |
| 2020 Q4 | 213.18 Million USD | 20.4% |
| 2020 Q2 | -73 Million USD | -204.41% |
| 2020 Q1 | 69.91 Million USD | -53.74% |
| 2020 Q3 | 177.06 Million USD | 342.56% |
| 2019 Q2 | 74.49 Million USD | -49.42% |
| 2019 Q1 | 147.26 Million USD | 22.24% |
| 2019 Q3 | 113.56 Million USD | 52.46% |
| 2019 Q4 | 151.15 Million USD | 33.09% |
| 2019 FY | - USD | 4.27% |
| 2018 Q1 | 98.19 Million USD | -10.41% |
| 2018 FY | - USD | 31.94% |
| 2018 Q2 | 122.69 Million USD | 24.95% |
| 2018 Q3 | 125.2 Million USD | 2.05% |
| 2018 Q4 | 120.47 Million USD | -3.78% |
| 2017 Q1 | 69.54 Million USD | -8.0% |
| 2017 FY | - USD | 29.56% |
| 2017 Q2 | 92.44 Million USD | 32.94% |
| 2017 Q3 | 108.73 Million USD | 17.62% |
| 2017 Q4 | 109.6 Million USD | 0.8% |
| 2016 Q2 | 70.22 Million USD | 20.82% |
| 2016 FY | - USD | 32.08% |
| 2016 Q4 | 75.58 Million USD | 9.58% |
| 2016 Q3 | 68.98 Million USD | -1.78% |
| 2016 Q1 | 58.12 Million USD | -9.46% |
| 2015 Q4 | 64.2 Million USD | 68.75% |
| 2015 FY | - USD | -2.27% |
| 2015 Q1 | 53.23 Million USD | -4.74% |
| 2015 Q2 | 42.32 Million USD | -20.49% |
| 2015 Q3 | 38.04 Million USD | -10.11% |
| 2014 FY | - USD | -13.72% |
| 2014 Q2 | 48.73 Million USD | 16.57% |
| 2014 Q1 | 41.8 Million USD | -26.79% |
| 2014 Q3 | 55.88 Million USD | 14.68% |
| 2014 Q4 | 55.88 Million USD | -0.01% |
| 2013 Q3 | 45.32 Million USD | 8.57% |
| 2013 Q1 | 95.95 Million USD | 129.78% |
| 2013 FY | - USD | 51.06% |
| 2013 Q4 | 57.1 Million USD | 25.99% |
| 2013 Q2 | 41.74 Million USD | -56.49% |
| 2012 Q3 | 30.03 Million USD | -18.57% |
| 2012 Q4 | 41.75 Million USD | 39.04% |
| 2012 Q1 | 28.89 Million USD | 5.39% |
| 2012 FY | - USD | 74.81% |
| 2012 Q2 | 36.88 Million USD | 27.66% |
| 2011 FY | - USD | -1.8% |
| 2011 Q1 | 21.02 Million USD | 20.2% |
| 2011 Q2 | 17.18 Million USD | -18.25% |
| 2011 Q3 | 27.18 Million USD | 58.14% |
| 2011 Q4 | 27.41 Million USD | 0.86% |
| 2010 Q4 | 17.49 Million USD | -20.22% |
| 2010 FY | - USD | 401.2% |
| 2010 Q2 | 45.34 Million USD | 119.08% |
| 2010 Q1 | 20.69 Million USD | 20.14% |
| 2010 Q3 | 21.92 Million USD | -51.65% |
| 2009 Q2 | 7.07 Million USD | -31.34% |
| 2009 FY | - USD | -212.15% |
| 2009 Q3 | -56.89 Million USD | -904.57% |
| 2009 Q4 | 17.22 Million USD | 130.28% |
| 2009 Q1 | 10.29 Million USD | 8.08% |
| 2008 Q4 | 9.52 Million USD | -28.57% |
| 2008 FY | - USD | -39.45% |
| 2008 Q3 | 13.34 Million USD | 89.73% |
| 2008 Q2 | 7.03 Million USD | -8.55% |
| 2008 Q1 | 7.68 Million USD | -12.8% |
| 2007 Q1 | 8.6 Million USD | 157.88% |
| 2007 Q2 | 17.05 Million USD | 98.27% |
| 2007 Q3 | 11.73 Million USD | -31.21% |
| 2007 FY | - USD | 266.3% |
| 2007 Q4 | 8.81 Million USD | -24.84% |
| 2006 Q4 | -14.85 Million USD | -70.91% |
| 2006 FY | - USD | -292.64% |
| 2006 Q3 | -8.69 Million USD | -1032.03% |
| 2006 Q1 | -2.94 Million USD | -188.12% |
| 2006 Q2 | -768 Thousand USD | 73.91% |
| 2005 FY | - USD | -42.07% |
| 2005 Q1 | 4.96 Million USD | -42.99% |
| 2005 Q2 | 4.16 Million USD | -16.2% |
| 2005 Q4 | 3.34 Million USD | 362.1% |
| 2005 Q3 | 723 Thousand USD | -82.63% |
| 2004 FY | - USD | 1008.46% |
| 2004 Q1 | 3.32 Million USD | -37.57% |
| 2004 Q2 | 6.68 Million USD | 100.81% |
| 2004 Q3 | 6.12 Million USD | -8.3% |
| 2004 Q4 | 8.71 Million USD | 42.2% |
| 2003 FY | - USD | 105.84% |
| 2003 Q2 | -2.32 Million USD | 4.86% |
| 2003 Q4 | 5.23 Million USD | 33.01% |
| 2003 Q1 | -8.58 Million USD | 67.83% |
| 2003 Q3 | 3.61 Million USD | 272.09% |
| 2002 Q1 | -10.28 Million USD | 3.53% |
| 2002 FY | - USD | 43.06% |
| 2002 Q4 | -7.6 Million USD | 13.36% |
| 2002 Q3 | -9.95 Million USD | 29.05% |
| 2002 Q2 | -14.06 Million USD | -20.31% |
| 2001 Q2 | -15.69 Million USD | 32.82% |
| 2001 Q1 | -22.76 Million USD | 0.0% |
| 2001 FY | - USD | 13.93% |
| 2001 Q4 | -12.8 Million USD | 35.64% |
| 2001 Q3 | -16.04 Million USD | -8.33% |
| 2000 FY | - USD | -458.11% |
| 2000 Q1 | -7.73 Million USD | 0.0% |
| 1999 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | -49.77 Million USD | 1705.431% |
| BrainsWay Ltd. | -2.31 Million USD | 34675.465% |
| Cerus Corporation | -26.53 Million USD | 3111.151% |
| Envoy Medical, Inc. | -18.23 Million USD | 4481.177% |
| electroCore, Inc. | -17.76 Million USD | 4599.093% |
| Helius Medical Technologies, Inc. | -12.1 Million USD | 6699.81% |
| IceCure Medical Ltd | -15.25 Million USD | 5338.569% |
| Inogen, Inc. | -45.67 Million USD | 1849.248% |
| OrthoPediatrics Corp. | -8.38 Million USD | 9633.934% |
| Lucid Diagnostics Inc. | -49.75 Million USD | 1706.076% |
| Monogram Orthopaedics, Inc. | -16.85 Million USD | 4840.469% |
| MaxCyte, Inc. | -44.12 Million USD | 1910.73% |
| NeuroOne Medical Technologies Corporation | -11.75 Million USD | 6896.87% |
| Nexalin Technology, Inc. | -5.69 Million USD | 14137.827% |
| Orthofix Medical Inc. | -86.98 Million USD | 1018.594% |
| PAVmed Inc | -75.74 Million USD | 1154.948% |
| Rapid Micro Biosystems, Inc. | -53.75 Million USD | 1586.363% |
| RxSight, Inc. | -41.03 Million USD | 2047.118% |
| Sight Sciences, Inc. | -49.41 Million USD | 1716.997% |
| SI-BONE, Inc. | -34.44 Million USD | 2419.686% |
| TELA Bio, Inc. | -40.63 Million USD | 2066.478% |
| Treace Medical Concepts, Inc. | -39 Million USD | 2148.398% |
| Vivos Therapeutics, Inc. | -16.67 Million USD | 4891.838% |
| Acutus Medical, Inc. | -13.48 Million USD | 6024.512% |
| Talis Biomedical Corporation | -66.04 Million USD | 1309.84% |
| Spectral AI, Inc. | -12.26 Million USD | 6616.384% |
| Nano-X Imaging Ltd. | -47.69 Million USD | 1775.38% |
| CVRx, Inc. | -38.73 Million USD | 2163.048% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | 22748.498% |
| PetVivo Holdings, Inc. | -10.49 Million USD | 7713.891% |
| Bioventus Inc. | -23.07 Million USD | 3563.541% |
| Venus Concept Inc. | -26.11 Million USD | 3159.928% |
| TriSalus Life Sciences, Inc. | -58.29 Million USD | 1470.611% |
| LivaNova PLC | 39.01 Million USD | -1947.978% |
| 908 Devices Inc. | -34.02 Million USD | 2448.388% |
| Alphatec Holdings, Inc. | -110.59 Million USD | 822.511% |
| Nemaura Medical Inc. | -7.28 Million USD | 11065.181% |
| NeuroPace, Inc. | -22.83 Million USD | 3599.339% |
| LENSAR, Inc. | -8.71 Million USD | 9269.601% |
| Apyx Medical Corporation | -18.11 Million USD | 4511.655% |
| Cutera, Inc. | -136.56 Million USD | 685.115% |
| STRATA Skin Sciences, Inc. | -3.38 Million USD | 23740.207% |
| BioSig Technologies, Inc. | -28.15 Million USD | 2938.404% |
| Anika Therapeutics, Inc. | 2.51 Million USD | -31658.307% |
| ClearPoint Neuro, Inc. | -20.98 Million USD | 3906.942% |
| Integra LifeSciences Holdings Corporation | 383.56 Million USD | -108.317% |
| Axonics, Inc. | 7.77 Million USD | -10177.029% |
| Outset Medical, Inc. | -153.78 Million USD | 619.568% |
| IRIDEX Corporation | -7.44 Million USD | 10828.236% |
| PROCEPT BioRobotics Corporation | -98.09 Million USD | 914.556% |
| IRadimed Corporation | 20.8 Million USD | -3741.416% |
| Tivic Health Systems, Inc. | -8.06 Million USD | 10011.177% |
| INVO Bioscience, Inc. | -6.88 Million USD | 11713.9% |
| Telesis Bio, Inc. | -40.49 Million USD | 2073.277% |
| Viemed Healthcare, Inc. | 36.67 Million USD | -2078.583% |
| Varex Imaging Corporation | 67.2 Million USD | -1089.046% |
| Quipt Home Medical Corp. | 44.07 Million USD | -1713.072% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | 7450.865% |
| Pulmonx Corporation | -55.09 Million USD | 1550.372% |
| Dynatronics Corporation | -976 Thousand USD | 81968.079% |
| Modular Medical, Inc. | -17.1 Million USD | 4771.923% |
| ReShape Lifesciences Inc. | -14.48 Million USD | 5616.32% |
| Semler Scientific, Inc. | 23.58 Million USD | -3287.337% |
| InMode Ltd. | 196.28 Million USD | -307.085% |
| Bruker Corporation | 599 Million USD | -33.395% |
| Cytosorbents Corporation | -28.81 Million USD | 2873.399% |
| DexCom, Inc. | 916.7 Million USD | 12.835% |
| Viveve Medical, Inc. | -20.61 Million USD | 3975.632% |
| ZimVie Inc. | 91.07 Million USD | -777.361% |
| Movano Inc. | -29.12 Million USD | 2843.482% |
| Cytek Biosciences, Inc. | -4.4 Million USD | 18227.023% |
| Nexalin Technology, Inc. | -5.69 Million USD | 14137.827% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | 22748.498% |
| Tandem Diabetes Care, Inc. | -194.65 Million USD | 510.486% |
| Profound Medical Corp. | -27.12 Million USD | 3045.934% |
| Insulet Corporation | 323.6 Million USD | -146.922% |
| enVVeno Medical Corporation | -25.01 Million USD | 3293.856% |
| Surmodics, Inc. | 1.18 Million USD | -67159.175% |
| iCAD, Inc. | -6.56 Million USD | 12271.196% |
| Nuwellis, Inc. | -16.35 Million USD | 4985.296% |
| Biotricity, Inc. | -8.82 Million USD | 9150.914% |
| iRhythm Technologies, Inc. | -96.86 Million USD | 924.925% |
| Aethlon Medical, Inc. | -11.84 Million USD | 6843.448% |
| InspireMD, Inc. | -20.91 Million USD | 3921.142% |
| PAVmed Inc. | -75.74 Million USD | 1154.948% |
| BIOLASE, Inc. | -15.13 Million USD | 5378.017% |
| Beyond Air, Inc. | -59.03 Million USD | 1453.592% |
| FONAR Corporation | 28.25 Million USD | -2728.3% |
| AxoGen, Inc. | -13.32 Million USD | 6095.191% |
| Vivani Medical, Inc. | -26.6 Million USD | 3103.003% |
| Tactile Systems Technology, Inc. | 24.54 Million USD | -3155.935% |
| Inari Medical, Inc. | 7.11 Million USD | -11133.502% |
| UFP Technologies, Inc. | 72.74 Million USD | -998.441% |
| QT Imaging Holdings, Inc. | -3.38 Million USD | 23699.808% |
| Heart Test Laboratories, Inc. | -6.15 Million USD | 13079.851% |
| Tenon Medical, Inc. | -15.52 Million USD | 5245.795% |
| Autonomix Medical, Inc. Common Stock | -15.26 Million USD | 5334.108% |
| Co-Diagnostics, Inc. | -41.47 Million USD | 2026.52% |
| AdaptHealth Corp. | -171.09 Million USD | 567.026% |
| Sintx Technologies, Inc. | -6.6 Million USD | 12206.652% |
| NanoVibronix, Inc. | -3.43 Million USD | 23361.689% |
| Quanterix Corporation | -38.08 Million USD | 2197.876% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | 7450.865% |
| Sensus Healthcare, Inc. | 30 Thousand USD | -2663363.333% |
| Pacific Biosciences of California, Inc. | -277.28 Million USD | 388.168% |
| TransMedics Group, Inc. | -7.6 Million USD | 10609.523% |
| ReWalk Robotics Ltd. | -21.76 Million USD | 3771.211% |
| NeuroMetrix, Inc. | -7.09 Million USD | 11360.717% |
| Hyperfine, Inc. | -47.06 Million USD | 1797.879% |
| Establishment Labs Holdings Inc. | -58.3 Million USD | 1470.4% |
| Biomerica, Inc. | -5.99 Million USD | 13432.872% |
| Bone Biologics Corporation | 479.57 Thousand USD | -166515.023% |
| AVITA Medical, Inc. | -39.56 Million USD | 2119.419% |
| Bluejay Diagnostics, Inc. | -9.17 Million USD | 8810.835% |
| Silk Road Medical, Inc | -45.08 Million USD | 1872.491% |